scorecardresearch
Add as a preferred source on Google
Saturday, January 3, 2026
TopicCholesterol

Topic: cholesterol

Daily statins vs ‘one-and-done’ gene therapy: India watches a cholesterol shift

A report on gene-editing drugs renews debate around long-term statin use as Indian cardiologists caution that risk assessment still guides therapy.

Experimental drug promising to bring down bad cholesterol by up to 69% completes early stage trial

Set to enter larger trial across 5 countries, it works by permanently turning off gene that causes high bad cholesterol levels. Commonly used drugs work by inhibiting cholesterol-causing enzyme.

Cardiovascular monitoring via nanotech. IIT-Guwahati researchers’ device promises faster, precise test

It is still in initial stages & could eventually be integrated with mobile phones, enabling patients to monitor blood health on the go. Clinical trials conducted with around 50 patients.

India gets 1st guidelines for managing lipid levels, the biggest risk factor for heart attack, stroke

For the first time, the guidelines are aimed at clinicians, individuals and medical laboratories. The cut-off for various lipid markers was modified based on risk factors.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

On Camera

Savitribai Phule made space for radical women misfits. She pioneered Satyashodhak modernity

The distinctiveness of her writing is evident in her compositions—women, shudras, and atishudras are at the center. Her poetry challenges the aesthetics of 'modern' Marathi literature.

India’s urban co-op banks are turning the page—crisis to cautious revival, one metric at a time

With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.